• Analyst coverage
  • Consensus
  • Discover more
Component content

Analyst coverage
Below are listed the sell-side analysts that cover Givaudan on a regular basis.

InstitutionNameRecommendation
Baader HelveaKonstantin Wiechertreduce
Bank of AmericaMatthew Yatesneutral
BarclaysAlex Sloaneneutral
Berenberg BankSamantha Darbyshirehold
BNP Paribas ExaneNicola Tangneutral
Bryan GarnierPhilippine Adambuy
CICVirginie Royere Roumageneutral
Citi Investment ResearchRanulf Orrneutral
Davy ResearchCathal Kennyneutral
Deutsche BankVirginie Boucher-Fertéhold
DZ Bank AGThomas Maulhold
Goldman Sachs InternationalGeorgina Fraserbuy
JefferiesCharles Bentleyunderperform
JP MorganCeline Pannutineutral
Kepler CheuvreuxPatrick Roquasbuy
Morgan StanleyLisa De Neveunderweight
MorningstarDiana Raduunderperform
Redburn AtlanticArtem Chubarovneutral
Research PartnersEugen Pergerhold
Stifel Europe Bank AGIsha Sharmahold
UBSCharles Edenneutral
Van Lanschot KempenEric Wilmerneutral
VontobelArben Hasanajbuy
Zürcher KantonalbankDaniel Buerkioutperform
Consensus
Component content

Consensus
The consensus forecasts, compiled by Givaudan, are based on emails and reports received between 11 and 20 September 2024.

Disclaimer:

The consensus forecast set out below results from regular research reports made by analysts currently covering Givaudan, as detailed in the list below. This list has been drawn up to the best of Givaudan’s knowledge but does not purport to be comprehensive of all institutions publishing financial research on Givaudan.

Any opinions, forecasts, estimates, projections or predictions regarding Givaudan’s performance made by the analysts are exclusively theirs and do not represent the opinions, forecasts, estimates, projections or predictions of Givaudan or its management. The publication of this information on this website does not imply that Givaudan endorses, or concurs with, the reports, conclusions or recommendations of the cited analysts. Givaudan disclaims any liability for the accuracy or completeness of such information and does not assume any obligation to update it even if it becomes aware of any changes.

This information is provided for ease of reference only and does not constitute an offer or solicitation to buy, hold or sell Givaudan securities.

in millions of Swiss francsFY 2023 AFY 2024 EFY 2025 E 9M 2023 A9M 2024 EQ3 2023 AQ3 2024 E
Group sales6,915   5,265 1,730 
- High 7,4077,982  5,640 1,902
- Average 7,3287,642  5,599 1,857
- Low 7,1217,381  5,535 1,783
LFL Group sales growth (%)4.1%   2.9% 4.0% 
- High 11.7%6.0%  12.4% 12.2%
- Average 10.4%4.7%  11.8% 10.4%
- Low 7.0%2.9%  10.0% 6.2%
Fragrance & Beauty ( F&B) sales3,312   2,511 839 
- High 3,6443,956  2,772 945
- Average 3,5953,751  2,745 916
- Low 3,4883,630  2,710 880
LFL F&B sales growth (%)7.6%   6.4% 6.5% 
- High 13.8%7.0%  15.0% 14.4%
- Average 12.3%4.5%  14.0% 11.5%
- Low 10.2%1.2%  11.9% 5.5%
Taste & Wellbeing (T&W) sales3,603   2,754 891 
- High 3,7924,025  2,882 970
- Average 3,7363,894  2,853 941
- Low 3,6333,751  2,818 902
LFL T&W sales growth (%)1.1%   0.0% 1.7% 
- High 10.0%5.7%  10.3% 11.2%
- Average 8.6%4.8%  9.6% 9.0%
- Low 5.2%4.0%  8.7% 6.2%
 
Comparable EBITDA Group1,547    
- High 1,8251,951  
- Average 1,7731,849  
- Low 1,7021,743  
Comparable EBITDA margin (%)22.4%    
- High 24.6%25.0%  
- Average 24.2%24.2%  
- Low 23.8%23.2%  
Fragrance & Beauty (F&B) sales817    
- High 1,0051,024  
- Average 967978  
- Low 889899  
F&B EBITDA margin (%)24.7%    
- High 27.7%27.6%  
- Average 27.0%26.1%  
- Low 25.5%24.0%  
Taste & Wellbeing (T&W) sales730    
- High 842975  
- Average 803870  
- Low 763819  
T&W EBITDA margin (%)20.3%    
- High 22.2%24.5%  
- Average 21.4%22.3%  
- Low 21.0%21.2%  
Reported EBITDA1,473    
- High 1,7771,921  
- Average 1,7241,833  
- Low 1,6521,723  
Reported EBITDA margin (%)21.3%    
- High 24.0%24.7%  
- Average 23.5%24.0%  
- Low 23.0%22.8%  
 
Net income reported 893    
- High 1,1591,227  
- Average 1,1001,146  
- Low 1,0401,068  
 
Free cash flow reported920    
- High 1,2221,170  
- Average 1,0261,091  
- Low 848955  
Free cash flow as a % of sales13.3%    
- High 16.5%15.3%  
- Average 14.0%14.3%  
- Low 11.5%12.7%  
 
Price target   
- High4,934 
- Average4,269 
- Low3,400 
 
Recommendation  
Buy5 
Hold10 
Sell2 
 
Number of estimates17 
 
Latest update19-09-2024 

Note: numbers might not sum-up because of rounding.

Discover more
Component content